Literature DB >> 3265404

Pancreatic function testing: serum PABA measurement is a reliable and accurate measurement of exocrine function.

A R Tanner1, D P Robinson.   

Abstract

A comparison between the NBT-PABA/14C-PABA test (NBT-PABA, n-benzoyl-tyrosyl para-aminobenzoic acid) using the PABA excretion index (PEI) and serum PABA estimation at 90 minutes has been made in 42 consecutive subjects attending for investigation of possible pancreatic disease to a District General Hospital (DGH). The PEI was unobtainable or incorrect on 38% of occasions compared with 9% for the serum test. Sensitivity, specificity, and efficiency for the PEI (n = 33 valid results) were 71%, 88%, and 79% respectively and for the serum PABA (n = 41 valid results), 95%, 90%, and 93% respectively. These results confirm that measurement of serum PABA is a simpler, more reliable, and a more accurate method of assessing pancreatic function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265404      PMCID: PMC1434113          DOI: 10.1136/gut.29.12.1736

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

1.  Brief study of the urinary PABA test for assessment of pancreatic exocrine function.

Authors:  G C Faulder; R C Strange
Journal:  Clin Chem       Date:  1984-09       Impact factor: 8.327

2.  Prospective comparison of three non-invasive tests for pancreatic disease.

Authors:  I Cobden; R Lendrum; O F James; C W Venables; I Tarbit; T Hawkins
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-29

3.  BT-PABA test with plasma PABA measurements: evaluation of sensitivity and specificity.

Authors:  J C Delchier; J C Soule
Journal:  Gut       Date:  1983-04       Impact factor: 23.059

4.  Observations on the BT PABA/14C-PABA tubeless test of pancreatic function.

Authors:  J M Braganza; G H Kay; V A Tetlow; K J Herman
Journal:  Clin Chim Acta       Date:  1983-06-15       Impact factor: 3.786

5.  Use of receiver operating characteristic curves to evaluate the clinical performance of analytical systems.

Authors:  E A Robertson; M H Zweig
Journal:  Clin Chem       Date:  1981-09       Impact factor: 8.327

6.  Relationship between PABA and Lundh tests: lack of influence of duodenal pH in vivo.

Authors:  G H Kay; V A Tetlow; J M Braganza
Journal:  Clin Chim Acta       Date:  1983-02-28       Impact factor: 3.786

7.  Value of serum PABA as a pancreatic function test.

Authors:  C Lang; K Gyr; I Tonko; D Conen; G A Stalder
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

8.  An evaluation of the one-day NBT-PABA/14C-PABA in the assessment of pancreatic exocrine insufficiency.

Authors:  A R Tanner; D Fisher; C Ward; C L Smith
Journal:  Digestion       Date:  1984       Impact factor: 3.216

9.  Pancreolauryl and NBT-PABA tests. Are serum tests more practicable alternatives to urine tests in the diagnosis of exocrine pancreatic insufficiency?

Authors:  P G Lankisch; J Brauneis; J Otto; B Göke
Journal:  Gastroenterology       Date:  1986-02       Impact factor: 22.682

10.  BT-Paba test in the diagnosis of pancreatic exocrine insufficiency in cystic fibrosis: urinary and serum determinations compared.

Authors:  S Bellentani; A Grisendi; M Rinaldi; P Bertolani; G Costa; M Agostini; G Mastella; F Balli; F Manenti
Journal:  Eur J Pediatr       Date:  1984-12       Impact factor: 3.183

  10 in total
  1 in total

1.  Diagnostic pitfall; interpretation of CA 19-9 concentrations in the presence of hepatic dysfunction.

Authors:  S Pearce; H Thornes; D Carr; A Tanner
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.